December 21, 2017 06:09 AM EST
Financing

Backed by Hen­ri Ter­meer es­tate, Au­ra rais­es $30M for work to pre­vent blind­ness in eye can­cer pa­tients

Brittany Meiling

Cam­bridge, MA biotech Au­ra Bio­sciences has raised $30 mil­lion in a Se­ries C round to take its light-ac­ti­vat­ed nanopar­ti­cle tech in­to late-stage tri­als for eye …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times